Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewBAY 41-2272 is an activator of soluble guanylyl cyclase (sGC); acts at a nitric oxide (NO)-independent regulatory site in the sGC α1 subunit. Inhibits platelet aggregation (IC50 = 36 nM) and phenylephrine-induced contractions of rabbit aorta (IC50 = 0.30 μM). Also reduces vascular smooth muscle growth through cAMP- and cGMP-dependent PKA and PKG pathways.
BAY 41-2272 is also offered as part of the Tocriscreen 2.0 Max. Find out more about compound libraries available from Tocris.
M. Wt | 360.39 |
Formula | C20H17FN6 |
Storage | Store at +4°C |
Purity | ≥98% (HPLC) |
CAS Number | 256376-24-6 |
PubChem ID | 9798973 |
InChI Key | ATOAHNRJAXSBOR-UHFFFAOYSA-N |
Smiles | FC(C=CC=C3)=C3CN2N=C(C4=NC=C(C5CC5)C(N)=N4)C1=CC=CN=C12 |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 36.04 | 100 |
The following data is based on the product molecular weight 360.39. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
1 mM | 2.77 mL | 13.87 mL | 27.75 mL |
5 mM | 0.55 mL | 2.77 mL | 5.55 mL |
10 mM | 0.28 mL | 1.39 mL | 2.77 mL |
50 mM | 0.06 mL | 0.28 mL | 0.55 mL |
References are publications that support the biological activity of the product.
Stasch et al (2010) NO-independent regulatory site on soluble guanylate cyclase. Nature 410 212 PMID: 11242081
Joshi et al (2011) The soluble guanylate cyclase stimulator BAY 41-2272 inhibits vascular smooth muscle growth through the cAMP-dependent protein kinase and cGMP-dependent protein kinase pathways. J.Pharmacol.Exp.Ther. 339 394 PMID: 21825001
Mittendorf et al (2009) Discovery of Riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension. ChemMedChem 4 853 PMID: 19263460
If you know of a relevant reference for BAY 41-2272, please let us know.
Keywords: BAY 41-2272, BAY 41-2272 supplier, activators, soluble, guanylyl, guanylate, cyclases, sGC, BAY41-2272, Guanylyl, Cyclase, Other, Nitric, Oxide, Enzyme, Substrates, /, Activators, 4430, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for BAY 41-2272 include:
Aly et al (2019) Endothelial Sash1 Is Required for Lung Maturation through Nitric Oxide Signaling. Cell Rep 27 1769-1780.e4 PMID: 31067462
Do you know of a great paper that uses BAY 41-2272 from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review BAY 41-2272 and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image